List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 874 studies with search of: Finland
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
2 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
3 Recruiting Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Condition: Pain
Interventions: Drug: AZD1386;   Drug: AZD1386;   Other: placebo
4 Completed Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
Condition: Cardiovascular Disease
Intervention: Drug: atorvastatin
5 Active, not recruiting Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Conditions: Migraine;   Migraine Headache;   Migraine Disorders;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: AST-726 Low dose;   Drug: AST-726 High dose;   Drug: AST-726 Placebo
6 Active, not recruiting Nutritional Prevention Pilot Trial for Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Dietary Supplement: A highly hydrolyzed formula;   Dietary Supplement: A regular cow's milk based formula
7 Recruiting A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: AIO-IRI, FOLFIRI, CAPIRI or XELIRI;   Drug: FUFOX, FOLFOX, CAPOX or XELOX
8 Active, not recruiting Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: AVODART;   Drug: Tamsulosin
9 Completed Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Conditions: Hypertension;   Hyperlipidemia
Intervention: Drug: Amlodipine/atorvastatin single pill
10 Recruiting Long-Term Safety Study of Lu AA21004 in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Lu AA21004
11 Recruiting Supplemental Oxygen in Vascular Surgery
Conditions: Surgical Wound Infection;   Vascular Surgery
Intervention: Other: supplemental postoperative oxygen
12 Completed Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: UK-369,003;   Drug: Placebo
13 Completed Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)
Condition: Pneumonia
Intervention: Drug: Venticute
14 Recruiting Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: prednisone
15 Active, not recruiting A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Platinum-based chemotherapy
16 Completed A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
Conditions: Lower Urinary Tract Symptoms;   Prostatic Hyperplasia
Interventions: Drug: tamsulosin hydrochloride;   Drug: solifenacin succinate;   Drug: Placebo
17 Active, not recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
Intervention: Drug: Dutasteride
18 Completed SA4503 8-Week Study in Major Depressive Disorder (MDD)
Condition: Depressive Disorder, Major
Interventions: Drug: placebo;   Drug: SA4503 Low;   Drug: SA4503 High
19 Recruiting Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: Serogroup B meningococcal Vaccine lot 1 (rMenB+OMV NZ Lot 1);   Biological: Serogroup B meningococcal Vaccine lot 2 (rMenB+OMV NZ Lot 2);   Biological: Serogroup B meningococcal Vaccine lot 3 (rMenB+OMV NZ Lot 3);   Biological: Combined DTaP-IPV-HBV-Hib vaccine or Pneumococcal 7-valent Conjugate Vaccine;   Biological: Meningococcal group C oligosaccharide conjugate vaccine
20 Recruiting Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
Conditions: Oral Contraceptive;   Headache;   Pelvic Pain
Interventions: Drug: EV/DNG (Qlaira, BAY86-5027, SH T00658ID);   Drug: Encapsulated Microgynon + Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services